Clinical Trial Update: Postoperative Sugammadex After COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining postoperative use of sugammadex in patients with or undergoing COVID-19-related anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Korea University Ansan Hospital | Conditions: General Anesthesia, COVID-19 | Phase 4 | Status: UNKNOWN